(Q43282879)

English

Phase I and biomarker study of ABT-869, a multiple receptor tyrosine kinase inhibitor, in patients with refractory solid malignancies

scientific article published on 31 August 2009

Statements

Phase I and biomarker study of ABT-869, a multiple receptor tyrosine kinase inhibitor, in patients with refractory solid malignancies (English)
0 references
Chiung-Ing Wong
Tong-San Koh
Ross Soo
Septian Hartono
Choon-Hua Thng
Evelyn McKeegan
Wei-Peng Yong
Chien-Shing Chen
Soo-Chin Lee
John Wong
Robert Lim
Norita Sukri
Siew-Eng Lim
Ai-Bee Ong
Joyce Steinberg
Neeraj Gupta
Rajendra Pradhan
Rod Humerickhouse
Boon-Cher Goh
31 August 2009
4718-4726

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit